Monoethanolamine

Monoethanolamine

SCHEMBL27656115

CCCCCCCCCCCCCC(=O)C(OP(=O)(O)O)C(O)CO.NCCO

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MPL

The experimentally established mechanism targets of Monoethanolamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.46
SMPD1 P17405 3/20 0.41
LPAR6 P43657 1/20 0.39
LPAR1 Q92633 1/20 0.39
LPAR4 Q99677 1/20 0.39
LPAR5 Q9H1C0 1/20 0.39
LPAR2 Q9HBW0 1/20 0.39
LPAR3 Q9UBY5 1/20 0.39
ENPP2 Q13822 1/20 0.39
PLA2G4A P47712 2/20 0.38
KDM4E B2RXH2 1/20 0.38
DUSP3 P51452 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9362645 0.93 PTPN1 (0.48) PTPN1SMPD1LPAR6LPAR1LPAR4
SCHEMBL9367572 0.93 PTPN1 (0.48) PTPN1SMPD1LPAR6LPAR1LPAR4
SCHEMBL27627196 0.93 PTPN1 (0.48) PTPN1SMPD1LPAR6LPAR1LPAR4
SCHEMBL9362627 0.93 PTPN1 (0.48) PTPN1SMPD1LPAR6LPAR1LPAR4
Monoethanolamine SCHEMBL27676043 0.93 LPAR3 (0.46) LPAR6LPAR1LPAR4LPAR5LPAR2
SCHEMBL27504160 0.86 LPAR1 (0.50) LPAR6LPAR1LPAR4LPAR5LPAR2
SCHEMBL7454857 0.86 LPAR1 (0.50) LPAR6LPAR1LPAR4LPAR5LPAR2
Phosphoric Acid SCHEMBL29050544 0.85 MAPT (0.48) LPAR6LPAR1LPAR4LPAR5LPAR2
SCHEMBL30441738 0.84 PTPN1 (0.45) PTPN1SMPD1LPAR6LPAR1LPAR4
SCHEMBL15022342 0.84 PLA2G2C (0.46) LPAR6LPAR1LPAR4LPAR5LPAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100551365-C The method for preparing submicron particles of antineoplastic agents BAXTER INT (US) 2009-10-21 CN disclosed
CN-101309707-A Composition comprising lipoxygenase inhibitor and cyclodextrin BAXTER INT (US) 2008-11-19 CN disclosed
CN-1870987-A Process for preparing submicron particles of paclitaxel BAXTER INT (US) 2006-11-29 CN disclosed